
**O'Flynn Foundation 1198858 Receipts and payments accounts CC16a For the period** 06/05/2022 30/04/2023 **To from** 

## **Section A Receipts and payments** 

|||**Unrestricted**<br>**funds**||**Restricted**<br>**funds**||||**Endowment**<br>**funds**|**Endowment**<br>**funds**|||**Total funds**||**Last year**||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||**to the nearest**<br>**£**||**to the nearest**|**£**|||**to the nearest**|**£**|||**to the nearest £**||**to the nearest**|**£**|
|**A1**|**Receipts**|||||||||||||||
|Donations received||**15,960**|||**-**||||**-**|||**15,960**|||**-**|
|.||**-**|||**-**||||**-**|||**-**|||**-**|
|||**-**|||**-**||||**-**|||**-**|||**-**|
|||**-**|||**-**||||**-**|||**-**|||**-**|
|||**-**|||**-**||||**-**|||**-**|||**-**|
|||**-**|||**-**||||**-**|||**-**|||**-**|
|||**-**|||**-**||||**-**|||**-**|||**-**|
|||**-**|||**-**||||**-**|||**-**|||**-**|
||**_Sub total_**_(Gross income for_<br>_AR)_|**15,960**|||**-**||||**-**|||**15,960**|||**-**|
|||||||||||||||||
|**A2**|**Asset and investment sales,**|||||||||||||||
|**(see table).**||||||||||||||||
|||**-**||||**-**||||**-**||**-**||||
|||**-**||||**-**||||**-**||**-**|||**-**|



|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest**<br>**£**<br>**15,960**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**15,960**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**|**Total funds**<br>**to the nearest £**<br>**15,960**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**15,960**|**Total funds**<br>**to the nearest £**<br>**15,960**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**15,960**|**Last year**<br>**to the nearest £**|
|---|---|---|---|---|---|---|
|Donations received|**15,960**|**-**|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**15,960**||**-**|
|.|**-**|**-**||**-**||**-**|
||**-**|**-**||**-**||**-**|
||**-**|**-**||**-**||**-**|
||**-**|**-**||**-**||**-**|
||**-**|**-**||**-**||**-**|
||**-**|**-**||**-**||**-**|
||**-**|**-**||**-**||**-**|
|**_Sub total_**_(Gross income for_<br>_AR)_|**15,960**|**-**||**15,960**||**-**|
|**A2 Asset and investment sales,**<br>**(see table).**|**-**<br>**-**|**-**<br>**-**||**-**<br>**-**|||
||**-**|**-**|**-**<br>**-**|**-**|||
||**-**|**-**||**-**||**-**|
|**_Sub total_**|**-**|**-**|**-**|**-**||**-**|
|**_Total receipts_**<br>**A3 Payments**|||||||
||||**-**|**15,960**||**-**|
||||||||
|Grantspaid|**6,565**||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**6,565**||**-**|
|Fundraisingcosts|**2,160**|||**2,160**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
|**_Sub total_ **|**8,725**|||**8,725**||**-**|
||||||||
|**A4 Asset and investment**<br>**purchases, (see table)**|||||||
||**-**||**-**<br>**-**<br>**-**|**-**|||
||**-**|||**-**|||
|**_Sub total_ **|**-**|||**-**||**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**|||||||
||||**-**|**8,725**||**-**|
||||||||
||**7,235**||**-**|<br>**7,235**||**-**|
||**-**||**-**<br>**-**|**-**||**-**|
||**-**|||**-**||**-**|
||**7,235**||**-**|**7,235**||**-**|



CCXX R1 accounts (SS) 

15/01/2024 

1 



## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>Signed by one or two trustees on<br>behalf of all the trustees<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B5 Liabilities**<br>**B3 Investment assets**|Signature<br>**Details**<br>**Details**<br>Bank account<br>**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>**Details**|**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**7,235**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**7,235**<br>**-**<br>OK<br>OK<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name|**Endowment**<br>**funds**<br>**to nearest £**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**Endowment**<br>**funds**<br>**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
|||||
|||||



CCXX R2 accounts (SS) 

15/01/2024 

2 

